These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 28458352

  • 1. Preparation of an Ultrafine Rebamipide Ophthalmic Suspension with High Transparency.
    Matsuda T, Hiraoka S, Urashima H, Ogura A, Ishida T.
    Biol Pharm Bull; 2017; 40(5):665-674. PubMed ID: 28458352
    [Abstract] [Full Text] [Related]

  • 2. Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model.
    Urashima H, Okamoto T, Takeji Y, Shinohara H, Fujisawa S.
    Cornea; 2004 Aug; 23(6):613-9. PubMed ID: 15257002
    [Abstract] [Full Text] [Related]

  • 3. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
    Kinoshita S, Oshiden K, Awamura S, Suzuki H, Nakamichi N, Yokoi N, Rebamipide Ophthalmic Suspension Phase 3 Study Group.
    Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye.
    Ueda K, Matsumiya W, Otsuka K, Maeda Y, Nagai T, Nakamura M.
    BMC Ophthalmol; 2015 Jun 06; 15():58. PubMed ID: 26048396
    [Abstract] [Full Text] [Related]

  • 5. Effect of rebamipide ophthalmic suspension on the success of lacrimal stent intubation.
    Mimura M, Ueki M, Oku H, Sato B, Ikeda T.
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb 06; 254(2):385-9. PubMed ID: 26483146
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Short-Term Effects of Diquafosol and Rebamipide on Mucin 5AC Level on the Rabbit Ocular Surface.
    Hori Y, Kageyama T, Sakamoto A, Shiba T, Nakamura M, Maeno T.
    J Ocul Pharmacol Ther; 2017 Feb 06; 33(6):493-497. PubMed ID: 28346860
    [Abstract] [Full Text] [Related]

  • 7. Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits.
    Urashima H, Takeji Y, Okamoto T, Fujisawa S, Shinohara H.
    J Ocul Pharmacol Ther; 2012 Jun 06; 28(3):264-70. PubMed ID: 22304618
    [Abstract] [Full Text] [Related]

  • 8. Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjögren syndrome patients with or without punctal occlusions.
    Arimoto A, Kitagawa K, Mita N, Takahashi Y, Shibuya E, Sasaki H.
    Cornea; 2014 Aug 06; 33(8):806-11. PubMed ID: 24977983
    [Abstract] [Full Text] [Related]

  • 9. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice.
    Ohguchi T, Kojima T, Ibrahim OM, Nagata T, Shimizu T, Shirasawa T, Kawakita T, Satake Y, Tsubota K, Shimazaki J, Ishida S.
    Invest Ophthalmol Vis Sci; 2013 Nov 21; 54(12):7793-802. PubMed ID: 24168989
    [Abstract] [Full Text] [Related]

  • 10. The Effect of Rebamipide Ophthalmic Solution on Cytokine and Mucin Secretion in Culture of Conjunctival Epithelial Cells From the Cu, Zn-Superoxide Dismutase-1 (SOD-1) Knock-Down Mouse.
    Ogawa M, Simsek C, Kojima T, Nagata T, Igarashi A, Kawakita T, Dogru M, Shimazaki J, Tsubota K.
    Eye Contact Lens; 2019 Mar 21; 45(2):93-98. PubMed ID: 30365413
    [Abstract] [Full Text] [Related]

  • 11. A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye.
    Kinoshita S, Awamura S, Nakamichi N, Suzuki H, Oshiden K, Yokoi N, Rebamipide Ophthalmic Suspension Long-term Study Group.
    Am J Ophthalmol; 2014 Mar 21; 157(3):576-83.e1. PubMed ID: 24246575
    [Abstract] [Full Text] [Related]

  • 12. Enhancing Corneal Drug Penetration Using Penetratin for Ophthalmic Suspensions.
    Morofuji R, Kudo K, Honda T, Kinugasa S, Matsuo T, Okabe K.
    Biol Pharm Bull; 2024 Mar 21; 47(5):1033-1042. PubMed ID: 38797668
    [Abstract] [Full Text] [Related]

  • 13. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
    Kinoshita S, Awamura S, Oshiden K, Nakamichi N, Suzuki H, Yokoi N, Rebamipide Ophthalmic Suspension Phase II Study Group.
    Ophthalmology; 2012 Dec 21; 119(12):2471-8. PubMed ID: 23009892
    [Abstract] [Full Text] [Related]

  • 14. Effect of Rebamipide Ophthalmic Suspension on Intraocular Light Scattering for Dry Eye After Corneal Refractive Surgery.
    Igarashi A, Kamiya K, Kobashi H, Shimizu K.
    Cornea; 2015 Aug 21; 34(8):895-900. PubMed ID: 26020821
    [Abstract] [Full Text] [Related]

  • 15. Size effect of rebamipide ophthalmic nanodispersions on its therapeutic efficacy for corneal wound healing.
    Nagai N, Ito Y, Okamoto N, Shimomura Y.
    Exp Eye Res; 2016 Oct 21; 151():47-53. PubMed ID: 27423550
    [Abstract] [Full Text] [Related]

  • 16. Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits.
    Kawaguchi I, Kobayashi A, Higashide T, Takeji Y, Sakurai K, Kawaguchi C, Sugiyama K.
    PLoS One; 2017 Oct 21; 12(10):e0186714. PubMed ID: 29049370
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
    Cho HY, Yoon H, Park GK, Lee YB.
    Clin Ther; 2009 Nov 21; 31(11):2712-21. PubMed ID: 20110013
    [Abstract] [Full Text] [Related]

  • 18. Effect of rebamipide ophthalmic suspension on optical quality in the short break-up time type of dry eye.
    Koh S, Inoue Y, Sugmimoto T, Maeda N, Nishida K.
    Cornea; 2013 Sep 21; 32(9):1219-23. PubMed ID: 23676786
    [Abstract] [Full Text] [Related]

  • 19. Randomized Comparison Between Rebamipide Ophthalmic Suspension and Diquafosol Ophthalmic Solution for Dry Eye After Penetrating Keratoplasty.
    Kobashi H, Kamiya K, Shimizu K.
    J Ocul Pharmacol Ther; 2017 Sep 21; 33(1):13-18. PubMed ID: 27937084
    [Abstract] [Full Text] [Related]

  • 20. Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy.
    Tung NT, Park CW, Oh TO, Kim JY, Ha JM, Rhee YS, Park ES.
    J Pharm Pharmacol; 2011 Dec 21; 63(12):1539-47. PubMed ID: 22060284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.